Briefs: SMS Pharmaceuticals and Vimta Labs
News

Briefs: SMS Pharmaceuticals and Vimta Labs

EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility

  • By IPP Bureau | March 03, 2024

EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility

The European Directorate for the Quality of Medicines & HealthCare (EDQM) conducted a GMP inspection of SMS Pharmaceuticals Limited's Active Pharmaceutical Ingredient(API) manufacturing facility located at Vizianagaram, Andhra Pradesh from 28th February, 2024 to 01st March, 2024 and inspection is successful, the report is awaited.

Vimta Labs receives grants-in-aid of Rs. 4.09 crore for upgradation of food testing laboratory

Vimta Labs Ltd has received Grants-in-aid (GIA) of Rs. 4.09 crore from Ministry of Food Processing Industries for upgradation of Food Testing Laboratory at Vimta Life Sciences Facility Plot No.5, MN Science Technology Park, Genome Valley, Shameerpet, Hyderabad, Telangana.

Upcoming E-conference

Other Related stories

Startup

Digitization